Next report date
Report period
Q1 2024
EPS estimate
−0.59USD
Revenue estimate
—
−81.41 MUSD
18.11 M
Om Leap Therapeutics, Inc.
Sektor
Bransch
VD
Doug E. Onsi
Webbplats
Huvudkvarter
Cambridge
Employees (FY)
54
Grundat
2011
FIGI
BBG00DQ929W6
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
